Holen Sie sich die Stockscreener-App
15.98
1.20%
0.19
Schlusskurs vom Vortag:
$15.79
Offen:
$15.88
24-Stunden-Volumen:
1.81M
Relative Volume:
0.79
Marktkapitalisierung:
$4.15B
Einnahmen:
$6.41B
Nettoeinkommen (Verlust:
$1.30B
KGV:
6.9782
EPS:
2.29
Netto-Cashflow:
$646.00M
1W Leistung:
+8.49%
1M Leistung:
-6.88%
6M Leistung:
-23.87%
1J Leistung:
+39.81%
1-Tages-Spanne:
$15.88
$16.15
1-Wochen-Bereich:
$14.75
$16.29
52-Wochen-Spanne:
$10.84
$23.10
Organon Co Stock (OGN) Company Profile
Firmenname
Organon Co
Sektor
Telefon
551-430-6000
Adresse
30 HUDSON STREET, JERSEY CITY
Vergleichen Sie OGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
15.98 | 4.15B | 6.41B | 1.30B | 646.00M | 2.29 |
|
LLY
Lilly Eli Co
|
788.19 | 752.65B | 40.86B | 8.37B | -2.28B | 5.4193 |
|
NVO
Novo Nordisk Adr
|
106.13 | 471.56B | 39.36B | 13.79B | 9.83B | 2.4077 |
|
JNJ
Johnson Johnson
|
155.40 | 353.35B | 87.70B | 14.68B | 19.03B | 13.47 |
|
ABBV
Abbvie Inc
|
183.08 | 323.72B | 55.53B | 5.12B | 15.62B | 3.65 |
|
MRK
Merck Co Inc
|
103.12 | 260.72B | 63.17B | 12.15B | 14.84B | 1.80 |
Organon Co Stock (OGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-06 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-11-03 | Herabstufung | Goldman | Buy → Neutral |
| 2023-09-21 | Eingeleitet | Barclays | Overweight |
| 2023-03-16 | Eingeleitet | Raymond James | Outperform |
| 2022-10-14 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-09-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-08-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-27 | Eingeleitet | Goldman | Buy |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-01 | Eingeleitet | BofA Securities | Buy |
| 2021-07-22 | Eingeleitet | Citigroup | Buy |
| 2021-06-15 | Eingeleitet | JP Morgan | Neutral |
| 2021-06-11 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-06-10 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Organon Co Aktie (OGN) Neueste Nachrichten
Algert Global LLC Has $2.20 Million Position in Organon & Co. (NYSE:OGN) - MarketBeat
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Organon & Co. (OGN): An Oversold Healthcare Stock to Invest In Now - Insider Monkey
Cerity Partners LLC Has $12.77 Million Stock Holdings in Organon & Co. (NYSE:OGN) - MarketBeat
(OGN) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Organon & Co. (NYSE:OGN) Stock Position Lifted by Victory Capital Management Inc. - MarketBeat
Massachusetts Financial Services Co. MA Sells 332,614 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
Organon (OGN): Company Profile, Stock Price, News, Rankings - Fortune
Thompson Siegel & Walmsley LLC Raises Stake in Organon & Co. (NYSE:OGN) - MarketBeat
Foundry Partners LLC Takes $7.64 Million Position in Organon & Co. (NYSE:OGN) - MarketBeat
Reach For A Dream and Organon Collaborate to Launch Dream Room at Rahima Moosa Mother and Child Hospital - Media Update
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It - MSN
Organon partners with Egyptian Drug Authority to advance women’s health and family planning in Egypt - ZAWYA
Beddow Capital Management Inc. Raises Holdings in Organon & Co. (NYSE:OGN) - MarketBeat
Organon: 7% Yield, 4x P/E, Big Upside Potential (NYSE:OGN) - Seeking Alpha
(OGN) Proactive Strategies - Stock Traders Daily
Organon & Co. (NYSE:OGN) Shares Sold by Principal Financial Group Inc. - MarketBeat
Organon & Co. (NYSE:OGN) Stock Holdings Decreased by OVERSEA CHINESE BANKING Corp Ltd - MarketBeat
Organon: Certainly A Risky Bet, But Looks Increasingly Compelling (Upgrade) - Seeking Alpha
Organon & Co (OGN) Stock Price Down 3.48% on Nov 12 - GuruFocus.com
Amalgamated Bank Sells 34,385 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
Los Angeles Capital Management LLC Boosts Stake in Organon & Co. (NYSE:OGN) - MarketBeat
Acorn Financial Advisory Services Inc. ADV Takes $743,000 Position in Organon & Co. (NYSE:OGN) - MarketBeat
Van ECK Associates Corp Increases Holdings in Organon & Co. (NYSE:OGN) - MarketBeat
Philip James Wealth Mangement LLC Invests $15.39 Million in Organon & Co. (NYSE:OGN) - MarketBeat
Ex-Dividend Reminder: American Water Works, Essential Utilities Inc and Organon - Nasdaq
Organon's (NYSE:OGN) Earnings Are Weaker Than They Seem - Yahoo Finance
Income Investors Should Know That Organon & Co. (NYSE:OGN) Goes Ex-Dividend Soon - Simply Wall St
Organon & Co (OGN) Stock Price Up 2.82% on Nov 7 - GuruFocus.com
FDA extends Organon's VTAMA cream review to March 2025 By Investing.com - Investing.com Canada
Organon & Co. (NYSE:OGN) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
Earnings Update: Organon & Co. (NYSE:OGN) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts - Yahoo Finance
Relative Strength Alert For Organon - Nasdaq
Organon updates outlook as FDA delays VTAMA label expansion - MSN
Organon reports FDA extension of target action date of review of Vtama sNDA - TipRanks
Organon’s VTAMA Cream FDA Review Extended to 2025 - TipRanks
Organon stock on watch as FDA delays VTAMA label (OGN:NYSE) - Seeking Alpha
FDA extends Organon's VTAMA cream review to March 2025 - Investing.com
(tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older - Business Wire
Organon's SWOT analysis: stock outlook amid VTAMA potential and biosimilar growth - Investing.com
Organon & Co (OGN) Stock Price Down 6.38% on Nov 4 - GuruFocus.com
Organon & Co. (NYSE:OGN) Trading Down 4.4%Should You Sell? - MarketBeat
The Organon & Co. (NYSE:OGN) Third-Quarter Results Are Out And Analysts Have Published New Forecasts - Simply Wall St
Organon China’s License and Supply Agreement with Shanghai Bao Pharmaceuticals - Global Legal Chronicle
(OGN) Technical Pivots with Risk Controls - Stock Traders Daily
Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28 - Yahoo Finance
Organon (OGN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - MSN
Private Management Group Inc. Has $36.23 Million Holdings in Organon & Co. (NYSE:OGN) - MarketBeat
FDA accepts Organon BLA for Prolia/Xgeva biosimilar - MSN
Organon Third Quarter 2024 Earnings: EPS: US$1.39 (vs US$0.23 in 3Q 2023) - Yahoo Finance
Organon & Co. (NYSE:OGN) to Issue $0.28 Quarterly Dividend - MarketBeat
Finanzdaten der Organon Co-Aktie (OGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):